Topiramate versus carbamazepine monotherapy for epilepsy: An individual participant data review

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 1, 2016, Pages

  Nolan, Sarah J ^a   Sudell, Maria ^a   Tudur Smith, Catrin ^a   Marson, Anthony G ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; TOPIRAMATE; ANTICONVULSIVE AGENT; FRUCTOSE;

ABSENCE; ARTICLE; COMPLEX PARTIAL SEIZURE; DRUG RESISTANT EPILEPSY; EPILEPSY; HUMAN; INTENTION TO TREAT ANALYSIS; MONOTHERAPY; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; REMISSION; SYSTEMATIC REVIEW; TONIC CLONIC SEIZURE; ANALOGS AND DERIVATIVES; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; INDUCTION CHEMOTHERAPY; META ANALYSIS; ANTICONVULSANT THERAPY; ANXIETY DISORDER; COCHRANE LIBRARY; DEPRESSION; DROWSINESS; DRUG EFFICACY; DRUG WITHDRAWAL; FATIGUE; FOCAL EPILEPSY; GASTROINTESTINAL SYMPTOM; HEADACHE; INCIDENCE; MEDLINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; SENSITIVITY ANALYSIS; SKIN TINGLING; TREATMENT DURATION; TREATMENT OUTCOME;

ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; EPILEPSY, TONIC-CLONIC; FRUCTOSE; HUMANS; INDUCTION CHEMOTHERAPY;

EID: 85002739986     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012065     Document Type: Article

References (56)

1. Annegers JF, Dubinsky S, Coan SP, Newmark ME, Roht L. The incidence of epilepsy and unprovoked seizures in multiethnic, urban health maintenance organizations. Epilepsia 1999;40(4):502-6.
2. Bell GS, Neligan A, Sander JW. An unknown quantity-The worldwide prevalence of epilepsy. Epilepsia 2014;55(7):958-962.
3. Brodie MJ, Dichter MA. Antiepileptic drugs. New England Journal of Medicine 1996;334(3):168-75.
4. Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD010236.pub2]
5. Cockerell OC, Johnson AL, Sander JW, Hart YM, Shorvon SD. Remission of epilepsy: results from the National General Practice Study of Epilepsy. The Lancet 1995;346(8968):140-4.
6. Coulter DA, Sombati S, DeLorenzo RJ. Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons. Epilepsia 1993;34(Suppl 2):123.
7. Microsoft . Microsoft Excel. Redmond, Washington: Microsoft, 2010.
8. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, et al. Appendix C: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. CONTINUUM Lifelong Learning in Neurology 2007;13(4):203-11.
9. Gilliam FG, Veloso F, Bomhof MA, Gazda SK, Biton V, Ter Bruggen JP, et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003;60(2):196-202.
10. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743-800.
11. Brozek J, Oxman A, Schunemann H. GRADEPro Version 3.6 for Windows. GRADE Working Group, 2004.
12. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota 1935 - 1984. Epilepsia 1993;34(3):453-68.
13. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
14. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
15. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders?. Neurology 2007;68(5):326-37.
16. Hunt S, Russell A, Smithson WH, Parsons L, Robertson I, Waddell R, et al. UK Epilepsy, Pregnancy Register. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008;71(4):272-6.
17. ILAE Commission on Antiepileptic Drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998;39(7):799-803.
18. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47(7):1094-120.
19. Juul-Jenson P, Foldspang A. Natural history of epileptic seizures. Epilepsia 1983;24(3):297-312.
20. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365.
21. Kwan P, Brodie MJ. Early identification of refractory epilepsy. New England Journal of Medicine 2000;342(5):314-9.
22. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org/.
23. Liporace JD, Sperling MR, Dichter MA. Absence seizures and carbamazepine in adults. Epilepsia 1994;35(5):1026-8.
24. MacDonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia 1995;36(Suppl 2):S2-12.
25. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JWA, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Annals of Neurology 2000;48(6):833-41.
26. Malfosse A, Genton P, Hirsch E, Marescaux C, Broglin D, Bernasconi R. Idiopathic Generalised Epilepsies: Clinical, Experimental and Genetic. Eastleigh: John Libbey and Company, 1994.. Idiopathic Generalised Epilepsies: Clinical, Experimental and Genetic. Eastleigh: John Libbey and Company, 1994.
27. Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW. Carbamazepine versus valproate monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD001030]
28. Matlow J, Koren G. Is carbamazepine safe to take during pregnancy?. Canadian Family Physician 2012;58(2):163-4.
29. Meador K, Reynolds M, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic reviews and meta-analysis of published pregnancy registries and cohorts. Epilepsy Research 2008;81(1):1-13.
30. Morrow J, Russel A, Guthrie E, Parsons L, Robertson I, Waddell R, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. Journal of Neurology, Neurosurgery, and Neuropsychiatry 2006;77(2):193-8.
31. Murray CJL, Lopez AD. Global Comparative Assessments in the Health Sector. Geneva: World Health Organization, 1994.
32. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010;51(5):883-90.
33. National Institute for Health and Care Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. London: National Institute for Health and Care Excellence 2012, Clinical Guidance 137.
34. Nolan SJ, Sutton L, Marson A, Tudur Smith C. Consistency of outcome and statistical reporting of time-to-event data: the impact on Cochrane Reviews and meta-analyses in epilepsy. Better Knowledge for Better Health. Proceedings of the 21st Cochrane Colloquium; 2013 September 19-23; Quebec City. Quebec City: The Cochrane Collaboration, 2013:114-5.
35. Nolan SJ, Marson AG, Pulman J, Tudur Smith C. Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD001769.pub2]
36. Nolan SJ, Muller M, Tudur Smith C, Marson AG. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD003615.pub3]
37. Nolan SJ, Tudur Smith C, Pulman J, Marson AG. Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalised onset tonic-clonic seizures. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD002217.pub2]
38. Nolan SJ, Sudell M, Weston J, Tudur Smith C, Marson A. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD011412]
39. Nolan SJ, Marson AG, Weston J, Tudur-Smith C. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. Cochrane Database of Systematic Reviews 2015, Issue 7. [DOI: 10.1002/14651858.CD001904.pub2]
40. Nolan SJ, Marson AG, Weston J, Tudur-Smith C. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database of Systematic Reviews 2015, Issue 8. [DOI: 10.1002/14651858.CD001911.pub2]
41. Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorfer D, Kjartansson O, Hauser WA. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurology 2005;4:627-34.
42. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
43. Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S, EPMN study group. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurologica Scandinavica 2003;107(3):165-75.
44. Ragsdale DS, Scheuer T, Catterall WA. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anaesthetic, antiarrhythmic, and anticonvulsant drugs. Molecular Pharmacology 1991;40(5):756-65.
45. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
46. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, et al. Sanad Study Group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. The Lancet 2007;369(9566):1000-15.
47. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, et al. Sanad Study Group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. The Lancet 2007;369(9566):1016-26.
48. Sander JW, Shorvon SD. Epidemiology of the epilepsies. Journal of Neurology, Neurosurgery, and Psychiatry 1996;61(5):433-43.
49. Sander JW. The use of anti-epileptic drugs - principles and practice. Epilepsia 2004;45(Suppl 6):28-34.
50. Shakir RA. Sodium valproate, phenytoin and carbamazepine as sole anticonvulsants. The Place of Sodium Valproate in the Treatment of Epilepsy. London: Academic Press Inc (London) Ltd and the Royal Society of Medicine, 1980:7-16.
51. Shields WD, Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 1983;33(11):1487-9.
52. Snead OC, Hosey LC. Exacerbation of seizures in children by carbamazepine. New England Journal of Medicine 1985;313(15):916-21.
53. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16.
54. Tudur Smith C, Marson AG, Chadwick DW, Williamson PR. Multiple treatment comparisons in epilepsy monotherapy trials. Trials 2007;5(8):34.
55. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Research 1997;28(3):167-79.
56. Williamson PR, Tudur Smith C, Hutton JL, Marson AG. Aggregate data meta-analysis with time-to-event outcomes. Statistics in Medicine 2002;21(11):3337-51.